New Zealand markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0630-0.0005 (-0.79%)
At close: 02:22PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
19,602
0
0
0
Operating expenses
Research development
17,381
25,923
36,936
16,956
Selling general and administrative
5,861
7,161
7,310
6,445
Total operating expenses
20,485
29,993
42,711
22,401
Operating income or loss
-883
-29,993
-42,711
-22,401
Total other income/expenses net
-436
-257
763
-9
Income before tax
-1,142
-30,371
-42,193
-22,333
Income from continuing operations
-1,142
-30,371
-42,193
-22,333
Net income
-1,142
-30,371
-42,193
-22,333
Net income available to common shareholders
-1,142
-30,371
-46,320
-22,333
Basic EPS
-0.12
-1.62
-3.85
-2.44
Diluted EPS
-0.16
-1.62
-3.85
-2.44
Basic average shares
32,173
18,777
12,292
9,169
Diluted average shares
40,885
18,777
12,292
9,169